Summary of Study ST002815
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001748. The data can be accessed directly via it's Project DOI: 10.21228/M8RQ7M This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002815 |
Study Title | Investigation of metabolism in hypertrophic cardiomyopathy - HILIC |
Study Summary | We propose the use of targeted metabolomics to define the metabolic and molecular pathways altered in 2 mouse models (R92W-TnT and R403Q-MHC) of hypertrophic cardiomyopathy (HCM) that span the spectrum of human disease (heart failure and sudden death), with the goal of identifying treatment targets. Parallel targeted metabolomics studies will be performed in heart tissue and plasma at rest and following inotrope stimulation. Since energy compromise is expected to be most marked when the heart is subject to increased workload, as is the case during high-intensity exercise or inotropic stimulation, we propose metabolomics studies in heart tissue and plasma, at rest and following inotrope stimulation. We anticipate that the results of these studies will allow us to move forward with further investigations into specific metabolites of interest as biomarkers, to be tested in HCM patients in future studies. |
Institute | University of California, San Francisco |
Department | Hypertrophic Cardiomyopathy Center of Excellence |
Laboratory | UCSF Smith Cardiovascular Research Building |
Last Name | Abraham |
First Name | Maria Roselle |
Address | 555 Mission Bay Boulevard South, San Francisco, CA 94158 |
Roselle.Abraham@ucsf.edu | |
Phone | 415-502-3911 |
Submit Date | 2023-07-27 |
Num Groups | 2 groups of 2 (i.e., mutant vs control of two mouse models of HCM (R402Q-MyHC, R92W-TnT) |
Total Subjects | 32 |
Raw Data Available | Yes |
Raw Data File Type(s) | wiff |
Analysis Type Detail | LC-MS |
Release Date | 2023-09-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001748 |
Project DOI: | doi: 10.21228/M8RQ7M |
Project Title: | Investigation of metabolism in hypertrophic cardiomyopathy |
Project Summary: | We propose the use of targeted metabolomics to define the metabolic and molecular pathways altered in 2 mouse models (R92W-TnT and R403Q-MHC) of hypertrophic cardiomyopathy (HCM) that span the spectrum of human disease (heart failure and sudden death), with the goal of identifying treatment targets. Parallel targeted metabolomics studies will be performed in heart tissue and plasma at rest and following inotrope stimulation. Since energy compromise is expected to be most marked when the heart is subject to increased workload, as is the case during high-intensity exercise or inotropic stimulation, we propose metabolomics studies in heart tissue and plasma, at rest and following inotrope stimulation. We anticipate that the results of these studies will allow us to move forward with further investigations into specific metabolites of interest as biomarkers, to be tested in HCM patients in future studies. |
Institute: | University of California, San Francisco |
Department: | Hypertrophic Cardiomyopathy Center of Excellence |
Laboratory: | UCSF Smith Cardiovascular Research Building |
Last Name: | Abraham |
First Name: | Maria Roselle |
Address: | 555 Mission Bay Boulevard South, San Francisco, CA 94158 |
Email: | Roselle.Abraham@ucsf.edu |
Phone: | 415-502-3911 |
Contributors: | Arpana Vaniya (avaniya@ucdavis.edu), Anja Karlstaedt (Anja.Karlstaedt@cshs.org) |
Subject:
Subject ID: | SU002924 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA302519 | M503 | Control MHC |
SA302520 | M438 | Control MHC |
SA302521 | M499 | Control MHC |
SA302522 | M492 | Control MHC |
SA302523 | M440 | Control MHC |
SA302524 | M485 | Control MHC |
SA302525 | M447 | Control MHC |
SA302526 | M487 | Control MHC |
SA302527 | T545 | Control TNT |
SA302528 | T547 | Control TNT |
SA302529 | T544 | Control TNT |
SA302530 | T518 | Control TNT |
SA302531 | T515 | Control TNT |
SA302532 | T524 | Control TNT |
SA302533 | T520 | Control TNT |
SA302534 | T522 | Control TNT |
SA302543 | MtdBlank002 | Method Blank |
SA302544 | MtdBlank001 | Method Blank |
SA302545 | MtdBlank003 | Method Blank |
SA302546 | MtdBlank005 | Method Blank |
SA302547 | MtdBlank007 | Method Blank |
SA302548 | MtdBlank004 | Method Blank |
SA302549 | MtdBlank006 | Method Blank |
SA302535 | M486 | MHC |
SA302536 | M483 | MHC |
SA302537 | M540 | MHC |
SA302538 | M498 | MHC |
SA302539 | M504 | MHC |
SA302540 | M439 | MHC |
SA302541 | M500 | MHC |
SA302542 | M441 | MHC |
SA302550 | Biorec006 | QC |
SA302551 | Biorec005 | QC |
SA302552 | Biorec007 | QC |
SA302553 | Biorec002 | QC |
SA302554 | Biorec001 | QC |
SA302555 | Biorec003 | QC |
SA302556 | Biorec004 | QC |
SA302557 | T523 | TNT |
SA302558 | T519 | TNT |
SA302559 | T525 | TNT |
SA302560 | T521 | TNT |
SA302561 | T540 | TNT |
SA302562 | T546 | TNT |
SA302563 | T542 | TNT |
SA302564 | T527 | TNT |
Showing results 1 to 46 of 46 |
Collection:
Collection ID: | CO002917 |
Collection Summary: | Excision while the heart still beating and flash freeze within 15 seconds of excision |
Sample Type: | Heart |
Treatment:
Treatment ID: | TR002933 |
Treatment Summary: | Saline IP and heparine SC injection in control & mutant group. After 10 minutes of saline injection we performed cervical dislocation, whole heart excision and flash freeze within 15 seconds of excision. |
Sample Preparation:
Sampleprep ID: | SP002930 |
Sampleprep Summary: | 2 mg of lyophilized tissue extracted with 1 mL 3:3:2 ACN/IPA/H2O 450 uL of extract dried and resuspended in 80:20 ACN/H2O. |
Combined analysis:
Analysis ID | AN004582 |
---|---|
Analysis type | MS |
Chromatography type | HILIC |
Chromatography system | Agilent 1290 |
Column | Waters ACQUITY UPLC BEH Amide (150 x 2.1mm,1.7um) |
MS Type | ESI |
MS instrument type | Triple TOF |
MS instrument name | ABI Sciex 6600 TripleTOF |
Ion Mode | POSITIVE |
Units | peak heights |
Chromatography:
Chromatography ID: | CH003443 |
Chromatography Summary: | Column: Waters Acquity UPLC BEH Amide Column, 1.7 μm, 2.1 mm x 150 mm); Pre-column: Waters Acquity UPLC BEH Amide VanGuard pre-column (1.7 μm , 5 mm × 2.1 mm;) |
Instrument Name: | Agilent 1290 |
Column Name: | Waters ACQUITY UPLC BEH Amide (150 x 2.1mm,1.7um) |
Column Temperature: | 40C |
Flow Gradient: | 0 min 100% (B), 0-2 min 100% (B), 2-7 min 70% (B), 7.7-9 min 40% (B), 9.5-10.25 min 30% (B), 10.25- 12.75 min 100% (B), 16.75 min 100% (B) |
Flow Rate: | 0.4 mL/min |
Solvent A: | Ultrapure water with 10 mM ammonium formiate + 0.125% formic acid, pH 3 |
Solvent B: | 95:5 v/v acetonitrile:ultrapure water w/ 10 mM ammonium formiate + 0.125% formic acid, pH 3 |
Chromatography Type: | HILIC |
MS:
MS ID: | MS004328 |
Analysis ID: | AN004582 |
Instrument Name: | ABI Sciex 6600 TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
MS Comments: | The triple time-of-flight (TTOF) mass spectrometers are operated with electrospray ionization (ESI) performing full scan in the mass range m/z 50-1500 in positive mode. Instrument parameters are as follows: Gas Temp 500°C, Ion Source Gas 1 50, Ion Source Gas 2 50, Curtain Gas 34, Ion Spray Voltage 4000 V. Data was collected in centroid mode, cycle time 0.5 seconds for a total of 1679 cycles. Full MS-ddMS/MS was acquired. |
Ion Mode: | POSITIVE |